Rapid Test Kit BD Veritor™ System Infectious Disease Immunoassay Influenza A + B Nasal Swab / Nasopharyngeal Swab Sample 30 Tests CLIA Waived (30/KT 12KT/CS) by BD ID 256045

188-1-6045
      
Stock Est. Shipping Date: 16th June 2025

Rapid Test Kit BD Veritor™ System Infectious Disease Immunoassay Influenza A + B Nasal Swab / Nasopharyngeal Swab Sample 30 Tests CLIA Waived (30/KT 12KT/CS)
Sold by: KT OF 30

 Reviews
Better together

  • Total: $0.00

Rally #188-1-6045
BD #256045
BD Veritor™ Plus System Flu A+B Kit (30 Test/KT)

Respiratory Test Kit, Flu A+B, Rapid Chromatographic Digital Immunoassay, Nasal & Nasopharyngeal Swab, Rx Only, CLIA Complexity Waived

Features
  • Helps user operation with single-button functionality that can potentially reduce manual test processing errors
  • Provides intuitive sample processing with prefilled, unitized tubes
  • Adapts easily to your workflow by offering 2 operational modes; Walk Away and Analyze Now
  • Displays easy-to-read digital results for flu in just 10 minutes
  • Provides clear, objective results by correcting for nonspecific binding and detecting positives not recognized by the unaided eye
  • Stores or downloads the lot number, patient/specimen ID, operator ID and test records using the BD Veritor™ InfoWiFi module or via the companion ImageMover application
  • Offers result printing capabilities via USB port
The BD Veritor™ System for Rapid Detection of Flu A+B is a rapid chromatographic immunoassay for the direct and qualitative detection of influenza A and B viral nucleoprotein antigens from nasal and nasopharyngeal swabs of symptomatic patients. The BD Veritor System for Rapid Detection of Flu A+B is a differentiated test, such that influenza A viral antigens can be distinguished from influenza B viral antigens from a single processed sample using a single device. The test is to be used as an aid in the diagnosis of influenza A and B viral infections.

A negative test is presumptive and it is recommended that these results be confirmed by viral culture or an FDA-cleared influenza A and B molecular assay. Negative test results do not preclude influenza viral infection and should not be used as the sole basis for treatment or other patient management decisions. The test is not intended to detect influenza C antigens.

A Certificate of Waiver is required to perform this test in a CLIA waived setting. To obtain a Certificate of Waiver, please contact your state health department.

Important Note:
  • Rx Only.
  • If put into refrigeration, do not freeze.
  • For in vitro diagnostic use.
  • Test kits is intended for use with the analyzer.
For the State of California:
Warning: This product can expose you to chemicals known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.

×
Rally #188-1-6045
Manufacturer #256045
GTIN00382902560456
BrandBD Veritor™ System
ManufacturerBD
Country of OriginUnknown
ApplicationRespiratory Test Kit
CLIA ComplexityWaived
For Use WithFor BD Veritor™ Plus Analyzer
Number of Tests30 Tests
Reading TypeMachine Read
Sample TypeNasal Swab / Nasopharyngeal Swab Sample
SpecialtyImmunoassay
Test FormatTest Device Format
Test Kit TypeRapid
Test MethodChromatographic Immunoassay
Test NameInfluenza A + B
Time to Results10 Minute Results
UNSPSC Code41116144
Storage Temperature2-30 °C (Do not Freeze)
Shelf Life (Days)1095

Type PPA NPA Results In
Influenza A
CLIA-Waived
83.6%
(76.1%, 89.1%)
97.5%
(95.7%, 98.5%)
10 minutes
Influenza B
CLIA-Waived
81.3%
(71.1%, 88.5%)
98.2%
(95.7%, 99.3%)
10 minutes

PPA = positive percent agreement
NPA = negative percent agreement




No recommended products at the moment.